Ausgabe 4/2022
Inhalt (12 Artikel)
Role of ELMO1 in inflammation and cancer—clinical implications
Stefania Tocci, Stella-Rita Ibeawuchi, Soumita Das, Ibrahim M. Sayed
Glioblastoma, from disease understanding towards optimal cell-based in vitro models
Chiara Boccellato, Markus Rehm
Application of circulating tumour cells to predict response to treatment in head and neck cancer
Xi Zhang, Chameera Ekanayake Weeramange, Brett G. M. Hughes, Sarju Vasani, Zhen Yu Liu, Majid Ebrahimi Warkiani, Gunter Hartel, Rahul Ladwa, Jean Paul Thiery, Liz Kenny, Chamindie Punyadeera
Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry
Ronghan Zhang, Xiaogang Chen, Shengwen Chen, Jiajia Tang, Feng Chen, Yong Lin, Peter Sol Reinach, Xiyun Yan, LiLi Tu, Hongxia Duan, Jia Qu, Qiang Hou
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer
Wang Chaomin, Niu Wenhao, Hua Jialei, Zhao Ting, Feng Honglei, Hao Zhuang, Wang Yichao, Bai Changsen, Li Yueguo
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer
B. B. M. Suelmann, A. Rademaker, C. van Dooijeweert, E. van der Wall, P. J. van Diest, C. B. Moelans
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma
Wenying Shu, Xue Zhu, Ke Wang, Svetlana Cherepanoff, R. Max Conway, Michele C. Madigan, Hong Zhu, Ling Zhu, Michael Murray, Fanfan Zhou
EV-miRome-wide profiling uncovers miR-320c for detecting metastatic colorectal cancer and monitoring the therapeutic response
Chan-Keng Yang, Hung-Chih Hsu, Yu-Hao Liu, Wen-Sy Tsai, Chung-Pei Ma, Yi-Tung Chen, Bertrand Chin-Ming Tan, Ying-Yu Lai, Ian Yi-Feng Chang, Chi Yang, Chia-Yu Yang, Jau-Song Yu, Hsuan Liu
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models
Shulin Li, Sanne J. M. Hoefnagel, Matthew Read, Sybren Meijer, Mark I. van Berge Henegouwen, Suzanne S. Gisbertz, Elena Bonora, David S. H. Liu, Wayne A. Phillips, Silvia Calpe, Ana C. P. Correia, Maria D. C. Sancho-Serra, Sandro Mattioli, Kausilia K. Krishnadath
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis
Pradeepa, Voddu Suresh, Shantibhusan Senapati, Soumen Chakraborty
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
Jiale Zhou, Junyun Wang, Wen Kong, Jin Zhang, Xiaorong Wu, Jiwei Huang, Junhua Zheng, Yonghui Chen, Wei Zhai, Wei Xue
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway
Huijie Miao, Yajun Geng, Yang Li, Shijie Tang, Feiling Feng, Weijian Li, Yongsheng Li, Liguo Liu, Rui Zhang, Shimei Qiu, Ying Wu, Zeyu Wang, Ziyi Wang, Ziyu Shao, Ke Liu, Lu Zou, Mao Yang, Yuhao Zhao, Chen Chen, Zhizhen Li, Dadong Zhang, Peng Peng, Xiaoyan Qiang, Frank Wu, Yongning He, Luonan Chen, Dongxi Xiang, Xiaoqing Jiang, Maolan Li, Yun Liu, Yingbin Liu